| Jose Alberto Canaca, MD | |
|
Msc10 5610, 1 University Of New Mexico, Albuquerque, NM 87131 | |
| (505) 272-6120 | |
| Not Available |
| Full Name | Jose Alberto Canaca |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 18 Years |
| Location | Msc10 5610, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033543772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | RS2013-0739 (New Mexico) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD2017-0877 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dhhs Ihs Phoenix Area | 8921265000 | 8 |
News Archive
The American Academy of Dermatology Association (AADA) is severely disappointed that Congress once again allowed partisan politics to stand in the way of a full sustainable growth rate (SGR) fix.
Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
Nursing homes serving primarily Hispanic residents provided poorer quality care compared to facilities whose patients were mostly white, according to Brown University research.
In a study of residents of Assisted Living Facilities in Los Angeles showed that 65% had clinically significant sleeping problems and that poor sleep was associated with declining quality of life and increased depression over a six month follow-up period. This study is published today in the Journal of the American Geriatrics Society.
› Verified 5 days ago
| Entity Name | Dhhs Ihs Phoenix Area |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548546609 PECOS PAC ID: 8921265000 Enrollment ID: O20120201000128 |
News Archive
The American Academy of Dermatology Association (AADA) is severely disappointed that Congress once again allowed partisan politics to stand in the way of a full sustainable growth rate (SGR) fix.
Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
Nursing homes serving primarily Hispanic residents provided poorer quality care compared to facilities whose patients were mostly white, according to Brown University research.
In a study of residents of Assisted Living Facilities in Los Angeles showed that 65% had clinically significant sleeping problems and that poor sleep was associated with declining quality of life and increased depression over a six month follow-up period. This study is published today in the Journal of the American Geriatrics Society.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose Alberto Canaca, MD Msc10 5610, 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (505) 272-6120 | Jose Alberto Canaca, MD Msc10 5610, 1 University Of New Mexico, Albuquerque, NM 87131 Ph: (505) 272-6120 |
News Archive
The American Academy of Dermatology Association (AADA) is severely disappointed that Congress once again allowed partisan politics to stand in the way of a full sustainable growth rate (SGR) fix.
Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
Nursing homes serving primarily Hispanic residents provided poorer quality care compared to facilities whose patients were mostly white, according to Brown University research.
In a study of residents of Assisted Living Facilities in Los Angeles showed that 65% had clinically significant sleeping problems and that poor sleep was associated with declining quality of life and increased depression over a six month follow-up period. This study is published today in the Journal of the American Geriatrics Society.
› Verified 5 days ago
Melissa A Merhege, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne Ste 213, Albuquerque, NM 87102 Phone: 505-727-7177 Fax: 505-727-3778 | |
Dr. Anju C Jaiswal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Children Psychiatric Hospital, 1001 Yale Blvd., Albuquerque, NM 87131 Phone: 505-272-2890 | |
George Edwin Davis, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1002 Idlewilde Ln Se, Albuquerque, NM 87108 Phone: 505-270-7479 | |
Shannon Stromberg, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Unm Psychiatric Ctr, 2600 Marble Ne, Albuquerque, NM 87131 Phone: 505-272-2800 Fax: 505-272-8692 | |
Liz-beth Porter, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Psychiatry, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Mr. Ronald Lee Romanik, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Suite D12, Albuquerque, NM 87109 Phone: 505-323-6969 Fax: 505-323-9696 | |
Dr. Justin F Beatty, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Msc 09 5030 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-2223 |